Innes Andrew
Department of Renal Medicine, Crosshouse Hospital, Kilmarnock, UK.
Nephrol Dial Transplant. 2008 Aug;23(8):2571-5. doi: 10.1093/ndt/gfn069. Epub 2008 Apr 5.
The late referral of patients with advanced chronic renal failure to a nephrologist is multifactorial but also compromises the preparations for dialysis and is prejudicial to their survival on dialysis. Measures that prompt or hasten referral, will allow preparation for dialysis, control of complications and treatment of comorbid conditions.
In June 2000, a programme was initiated to provide surveillance of plasma creatinines >300 micromol/L on all laboratory requests from general practitioners (GPs) and hospital clinicians in Ayrshire and Arran Health Board in southwest Scotland. Patients already known to the nephrologists were excluded. Results were regularly reviewed and further excluded if the creatinine fell or the patient died. For the remainder, a standard letter was sent to the requesting clinician suggesting renal referral if appropriate. This was to act as a prompt to the general practitioner or hospital clinician. For those referred over the 5-year period, the outcome was analysed in January 2007.
In the first 5 years (June 2000-June 2005) letters were sent regarding 246 patients (median age 76). Fifty-three patients still had reversible ARF or died within 3 months of the letter; seven were already referred. The requesting clinician felt that referral was not appropriate in 56; 23 were being reviewed elsewhere. The programme has led to the referral of 50 patients to the renal service (and 3 to others) but in 54 cases no reply was received and the letter ignored. Of the 50 referred, 17 entered the dialysis programme, 13 of whom had definitive dialysis access (fistula or Tenckhoff catheter) at the start. After a period of outpatient review they have undergone a median of 21 months of dialysis.
Over the 5-year period this programme has detected a cohort of patients who, in general, benefited from nephrological follow-up and dialysis. It may also act as a prompt to clinicians to refer more 'marginal' patients and thereby hasten future referral.
晚期慢性肾衰竭患者向肾病专家的延迟转诊是多因素导致的,但这也会影响透析准备工作,并对患者的透析生存情况产生不利影响。促使或加速转诊的措施将有助于进行透析准备、控制并发症以及治疗合并症。
2000年6月,启动了一项计划,对苏格兰西南部艾尔郡和阿伦健康委员会的全科医生(GP)及医院临床医生提交的所有实验室检查申请中血浆肌酐>300微摩尔/升的情况进行监测。已为肾病专家所知的患者被排除在外。定期审查结果,若肌酐水平下降或患者死亡则进一步排除。对于其余患者,向申请医生发送标准信函,建议在适当情况下进行肾脏转诊。这旨在促使全科医生或医院临床医生采取行动。对于在5年期间转诊的患者,于2007年1月分析其结局。
在最初的5年(2000年6月至2005年6月),共发送了关于246名患者(中位年龄76岁)的信函。53名患者仍患有可逆性急性肾衰竭或在信函发出后3个月内死亡;7名患者已被转诊。申请医生认为56名患者不适合转诊;23名患者正在其他地方接受评估。该计划已导致50名患者被转诊至肾脏科(3名转诊至其他科室),但有54例未收到回复且信函被忽视。在转诊的50名患者中,17名进入了透析计划,其中13名在开始时就有确定的透析通路(动静脉内瘘或Tenckhoff导管)。经过一段时间的门诊复查,他们接受透析的中位时间为21个月。
在这5年期间,该计划发现了一组总体上受益于肾病随访和透析的患者。它还可能促使临床医生转诊更多“边缘”患者,从而加快未来的转诊速度。